Have questions? Visit https://www.reddit.com/r/SNPedia

rs2652511

From SNPedia

Orientationminus
Stabilizedminus
Make rs2652511(C;C)
Make rs2652511(C;T)
Make rs2652511(T;T)
ReferenceGRCh38 38.1/141
Chromosome5
Position1446274
GeneSLC6A3
is asnp
is mentioned by
dbSNPrs2652511
ebirs2652511
HLIrs2652511
Exacrs2652511
Varsomers2652511
Maprs2652511
PheGenIrs2652511
hapmaprs2652511
1000 genomesrs2652511
hgdprs2652511
ensemblrs2652511
gopubmedrs2652511
geneviewrs2652511
scholarrs2652511
googlers2652511
pharmgkbrs2652511
gwascentralrs2652511
openSNPrs2652511
23andMers2652511
23andMe allrs2652511
SNP Nexus

SNPshotrs2652511
SNPdbers2652511
MSV3drs2652511
GWAS Ctlgrs2652511
GMAF0.4013
Max Magnitude

[PMID 19091889] Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3



[PMID 19879111] Association of promoter variants of human dopamine transporter gene with schizophrenia in Han Chinese

[PMID 16894395]The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes.

[PMID 18802919]A common haplotype at the dopamine transporter gene 5' region is associated with attention-deficit/hyperactivity disorder.

[PMID 17044101]A promoter polymorphism (-839 C > T) at the dopamine transporter gene is associated with attention deficit/hyperactivity disorder in Brazilian children.

[PMID 16082688]No support for association between the dopamine transporter (DAT1) gene and ADHD.


[PMID 18553640] Genetic heterogeneity in ADHD: DAT1 gene only affects probands without CD.


[PMID 19196467OA-icon.png] Association study of promoter polymorphisms at the dopamine transporter gene in Attention Deficit Hyperactivity Disorder.


[PMID 20445798OA-icon.png] Chromosome 5p Region SNPs Are Associated with Risk of NSCLC among Women.


[PMID 20580759] Pharacogenetic effects of dopamine transporter gene polymorphisms on response to chlorpromazine and clozapine and on extrapyramidal syndrome in schizophrenia.


GET Evidence
rs2652511
aa_change
aa_change_short
impact pharmacogenetic
qualified_impact Insufficiently evaluated pharmacogenetic
overall_frequency 0.18
summary



[PMID 24487615] Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: findings from a sample of adults